12.5
中枢神経刺激剤: 幻覚剤
幻覚剤は、サイケデリックドラッグとも呼ばれ、知覚、認知、感情を変化させる能力があることで知られる物質のクラスです。精神に多大な影響を及ぼすにもかかわらず、これらの薬剤は中毒性がなく、他の多くの乱用物質とは一線を画しています。これらの薬剤の作用機序は、脳内の 5-HT_2A 受容体への影響にあります。…
幻覚剤や幻覚剤は、知覚、認知、感情を変える中毒性のない物質です。
それらは脳の5-HT2A受容体を活性化し、それがGqタンパク質に結合してIP3を生成し、最終的に細胞内カルシウム放出につながります。
幻覚剤は、その独特の化学構造に基づいて、主に2つのクラスに分類されます。
インドールアミンには、LSDやシロシビンなどの薬剤が含まれます。それらは、感覚の歪み、幻覚、および意識の変化状態を誘発します。
フェネチルアミンには、MDMA、メスカリン、PCPなどの薬剤が含まれます。
エクスタシーまたはモリーとして知られるMDMAは、覚醒剤とサイケデリックな効果の両方を提供し、共感と多幸感を引き出します。
PCPは当初麻酔薬として開発されましたが、高用量で感情的な離脱と攻撃性を引き起こしました。
幻覚剤は身体依存を引き起こさないが、急速な耐性の発現には薬物モニタリングまたは医学的介入が必要である。これには、患者の安心感、重度の興奮の場合のジアゼパムの投与、またはPCPの過剰摂取に対する生命維持が含まれます。.
View the full transcript and gain access to JoVE Core videos
Q1: How do psychedelic drugs affect the brain at the molecular level?
Psychedelic drugs activate the brain's 5-HT2A receptor, which couples to Gq-type G proteins. This triggers a biochemical cascade that releases intracellular calcium, producing the drugs' distinctive psychological effects. This mechanism underlies the altered perception, cognition, and emotions characteristic of hallucinogens.
Q2: What are the main chemical classes of hallucinogens?
Hallucinogens divide into two classes: indoleamines and phenethylamines. Indoleamines include LSD and psilocybin, producing vivid visual effects and altered consciousness. Phenethylamines include MDMA and PCP, with MDMA providing both stimulant and psychedelic effects, while PCP was originally developed as an anesthetic.
Q3: Why are psychedelic drugs considered non-addictive?
Psychedelic drugs do not cause physical dependence, distinguishing them from many other abused substances. However, rapid tolerance develops with regular use, requiring higher doses to achieve the same effects. While withdrawal symptoms can occur in some users, the absence of physical dependence classifies these drugs as non-addictive.
Q4: What are the distinct effects of MDMA compared to other hallucinogens?
MDMA, known as ecstasy or molly, uniquely provides both stimulant and psychedelic effects. It elicits feelings of empathy, euphoria, and heightened sensory perception. Unlike indoleamines that primarily produce visual distortions, MDMA's dual action creates a distinctive emotional and sensory experience.
Q5: How does PCP differ from other phenethylamines in its effects?
PCP, initially developed as an anesthetic, causes emotional withdrawal and aggressive behavior at high doses. Unlike MDMA, which produces empathy and euphoria, PCP's effects are primarily negative and potentially dangerous. Its anesthetic origins distinguish it chemically and functionally from other phenethylamines.
Q6: What medical interventions are used for hallucinogen overdose or severe reactions?
Treatment involves patient reassurance and administering diazepam for severe agitation. In cases of PCP overdose, life support may be necessary. These interventions address the rapid tolerance and acute psychological effects that can occur, though hallucinogens lack the physical dependence seen in drug abuse and addiction pharmacological phenomena.
Q7: What sensory and psychological effects do indoleamine hallucinogens produce?
Indoleamines like LSD and psilocybin induce sensory distortions, hallucinations, and profoundly altered states of consciousness. These drugs produce vivid visual effects and perceptual changes. Regular use leads to rapid tolerance, requiring higher doses to achieve the same psychological and sensory effects.